Susquehanna International Group’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-95,400
| Closed | -$488K | – | 14318 |
|
|
2021
Q3 | $488K | Sell |
95,400
-23,500
| -20% | -$143K | ﹤0.01% | 9456 |
|
|
2021
Q2 | $988K | Buy |
+118,900
| New | +$1M | ﹤0.01% | 7801 |
|
|
2021
Q1 | – | Sell |
-31,800
| Closed | -$345K | – | 13085 |
|
|
2020
Q4 | $345K | Sell |
31,800
-13,400
| -30% | -$165K | ﹤0.01% | 9001 |
|
|
2020
Q3 | $539K | Sell |
45,200
-47,800
| -51% | -$640K | ﹤0.01% | 7508 |
|
|
2020
Q2 | $1.49M | Sell |
93,000
-31,600
| -25% | -$552K | ﹤0.01% | 5044 |
|
|
2020
Q1 | $1.93M | Sell |
124,600
-531,000
| -81% | -$11.4M | ﹤0.01% | 4029 |
|
|
2019
Q4 | $16.1M | Buy |
655,600
+431,400
| +192% | +$6.4M | ﹤0.01% | 1616 |
|
|
2019
Q3 | $2.31M | Buy |
224,200
+188,600
| +530% | +$2.38M | ﹤0.01% | 3917 |
|
|
2019
Q2 | $447K | Buy |
35,600
+18,800
| +112% | +$242K | ﹤0.01% | 7505 |
|
|
2019
Q1 | $208K | Buy |
+16,800
| New | +$188K | ﹤0.01% | 7828 |
|
|
2018
Q3 | – | Sell |
-24,200
| Closed | -$328K | – | 10555 |
|
|
2018
Q2 | $328K | Buy |
+24,200
| New | +$377K | ﹤0.01% | 7666 |
|
|
2018
Q1 | – | Sell |
-69,000
| Closed | -$866K | – | 10476 |
|
|
2017
Q4 | $866K | Sell |
69,000
-64,800
| -48% | -$942K | ﹤0.01% | 5527 |
|
|
2017
Q3 | $2.55M | Buy |
133,800
+21,500
| +19% | +$328K | ﹤0.01% | 3482 |
|
|
2017
Q2 | $1.7M | Buy |
+112,300
| New | +$1.7M | ﹤0.01% | 4214 |
|
|
2016
Q4 | – | Sell |
-12,500
| Closed | -$123K | – | 10360 |
|
|
2016
Q3 | $123K | Buy |
+12,500
| New | +$114K | ﹤0.01% | 7861 |
|
|
2015
Q4 | – | Sell |
-147,000
| Closed | -$1.89M | – | 10168 |
|
|
2015
Q3 | $1.89M | Buy |
147,000
+112,800
| +330% | +$2.28M | ﹤0.01% | 4383 |
|
|
2015
Q2 | $821K | Buy |
34,200
+18,400
| +116% | +$354K | ﹤0.01% | 6616 |
|
|
2015
Q1 | $297K | Buy |
15,800
+5,600
| +55% | +$116K | ﹤0.01% | 7996 |
|
|
2014
Q4 | $192K | Sell |
10,200
-16,700
| -62% | -$390K | ﹤0.01% | 8851 |
|
|
2014
Q3 | $729K | Buy |
+26,900
| New | +$836K | ﹤0.01% | 6527 |
|
Other funds holding EPZM
Susquehanna International Group's EPZM Position: Q3 2022 in Review
Susquehanna International Group sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 184,964 shares — an estimated $272K sold.
Susquehanna International Group first reported a position in EPZM in Q2 2013 and held it in 19 quarters. The position peaked at $2.73M in Q2 2020. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.
- Susquehanna International Group reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
- Susquehanna International Group sold 184,964 Epizyme, Inc shares in Q3 2022, an estimated $272K.
- Susquehanna International Group first reported a position in Epizyme, Inc in Q2 2013 and held it in 19 quarters.
- Susquehanna International Group's Epizyme, Inc position peaked at $2.73M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.
Based on Susquehanna International Group's 13F filing for Q3 2022, filed 14 Nov 2022.